Participation by the Commission in the International Human Frontier Science Program Organisation. Communication from the Commission to the Council and the European Parliament. SEC (90) 1726 final, 12 September 1990. by unknown
COMMISSION  OF  THE  EUROPEAN  COMMUNITIES 
SEC(90)  1726  final  Brussels,  12  September  1990 
COMMUNICATION  FROM  THE  COMMISSION  TO  THE  COUNCIL 
AND  THE  EUROPEAN  PARLIAMENT 
Participation bY  the Commission  In  the 
International  Human  Frontier  Science Program  Organisation The  Commission  hereby  Informs  the Council  and  the European  Parliament  of  Its 
intent ion  to  represent  the  EEC  as  a  •  Management  Support lng  Party"  of  the 
International  Human  Frontier  Science  Program  Organisation,  for  the  trial 
period  to 31.3.92. 
1.  The  Human  Frontier  Science  Program  (HFSP)  Is  a  basic  research  funding 
programme  in  higher  order  brain  functions  and  molecular  level 
approaches  to  biological  functions.  It  promotes  an  International 
(worldwide)  and  Interdisciplinary  approach  to  baste  research  on  the 
characteristics  and  mechanisms  of  living  organisms,  and  w/11 
potentially  provide  seeds  and  toots  for  the  science  and  technology  of 
the  21st  century.  It  Is  Intended  that  research  results should  be  used 
for  the benefit of aft  mankind. 
2.  Based  on  an  In/ t1 atlve  presented  by  the  Japanese  government  to  the 
Venice  Economic  summit  of  June  19B7,  the  Programme  was  subsequently 
designed  by  an  International  committee  of  eminent  scientists,  and 
finally  became  operational  In  1989,  for  a  trial  period  of  three  years 
to  31.3.1992.  Its  founder  members  are  the  Summit  participant  (G7) 
countries,  and  the  Commission,  representing  the  European  Community, 
has  been  Invited  to  join. 
3.  The  two  main  research  areas  are  brain  functions  Including  perception, 
cognltfon,  memory,  learning,  etc.,  and  biological  functions  through 
molecular  level  approaches,  tnctudlng  molecular  recognition/response, 
energy  conversfon,  etc.  A  list  of  some  60  specific  priority  research 
topics  has  been  established  for  the  trial  period,  and  Is  annexed  to 
this note. 
4.  The  Programme  consists of the  following  activities: 
Grants 
projects 
to  support  International  joint 
for  support  are  selected  by  an 
review committee. 
research  teams; 
International  peer 
Fellowshtos- to enable scientists to work  abroad; 
Workshoos  International  meetings  to  exchange  views  and 
discuss  new  discoveries. 
5.  To  administer  the Programme  a  new  organisation ("a.s.b.l.·  under  French 
private  taw)  has  been  set  up,  with an  International  Secretariat  located 
in  Strasbourg.  HFSP  directional  management  /s  entrusted  to  a  Board  of 
Trustees  (governr::ent  represent  at /ves,  two  A/embers  nom/ nated  by  each 
Management  Supporting Party)  and  a  Council  of Scientists. 
c_  Programme  finance  during  the  trial  period  Is  provided  mainly  by  he 
Government  of  JD.pan,  with  some  contributions  (In  cash  or  Aind)  from 
wo~:t  of  the other  Management  Support lng  Part tes. 7.  HFSP  Is of  inherent  scientific  Interest  for  the European  Community,  and 
Its  overall  ambitions  relate  coherently  to  the  objectives  of  the  EC's 
Framework  Programme.  Uost  of  the  research  fields  it  targets  are  being 
addressed  within  existing  EC  programmes,  e.g.  BRIDGE,  SCIENCE,  ESPRIT, 
HUAIAN  GENOA!£.  A/ED/CAL  RESEARCH.  It  Is  Import ant  that  these  programmes 
maintain  Interface with related  frontier  research  througfJout  the world. 
8.  The  Human  Frontier  Science  Programme  /s  rapidly  taking  on  a  global 
dimension.  Switzerland,  Sweden  and  Australia  have  already  applied  to 
join  and  any  Individual  country  may  apply  for  membership  as  a 
Management  Supporting Party,  scientific capability being the principal 
criterion  for  participation. 
9.  The  Commission  considers  It  appropriate  to  ensure  full  and  balanced 
European  Community  participation  In  HFSP  operations,  both  in  order  to 
be  able  to  Influence  the  Programme's  evolution,  and  to  derive  maximum 
benefit  for  all  A/ember  States,  only  four  of  which  are  at  present 
members  In  their  own  right. 
10.  HFSP  Is  likely  to  have significant  Implications  for  the  future  of many 
industries.  While  Its  vocation  /s  to  promote  basic  research  in  the 
targeted  fields,  the  time  delay  between  significant  research 
breakthroughs  and  their  Industrial  exploitation  could  be  quite  short. 
Research  In  brain  functioning  and  molecular  biology  presently  enjoys 
rapid expansion.  and  spectacular  progress  /s expected  to continue  for 
several  years.  making  significant  Impacts  throughout  the  fields  of 
biotechnology  (I ncl  ud i ng  med leal  and  health-related  appllcat Ions)  and 
Information  technology. 
11.  Specifically  in  information  technologies,  areas  such  as  the  following 
could  be  rapidly  affected.:  the  mathematical  basis  for  neural  networks 
technology,  parallel  computing,  complex  databases,  learning  systems, 
pattern  recognition,  and  constraint  satisfaction  systems  for  speech, 
vision and  robotics,  and  expert  systems using neural  nets. 
12.  New  Insights  resulting  from  the  HFSP  In  the  field  of  molecular  level 
approaches  to  biological  functions  may  find  equally  rapid  applications 
in  the  pharmaceutical.  chemical  and  agricultural  Industries.  At  the 
same  t /me  HFSP  will  lead  to  Increased  demand  for  specific  laboratory 
equipment  and  Instrumentation,  which,  because  of  the  frontier 
technology  Involved,  will  lead  to  the  development  of  more  general 
commercial  applications. 
13.  Because  of  the  Industrial  potential  of  the  HFSP,  measures  for  the 
dissemination  of  results  to  European  Industry  should  be  taken, 
including using  and  developing  the mechanisms  already set  up  within  the 
Community's  R  &  D  programmes.  It  Is  envisaged  that  a  Commission 
interservlces  group  would  be  set  up  to  follow  the  evolution  of  the 
HFSP,  Including  the aspect  of  technology  transfer  to European  Industry, 
and  to  monitor  balanced  benefit  from  the  dissemination  of  the 
programme's  results. 
74.  In  order  that  the  EEC  shall  become  a  "Management  Supporting  Party"  of 
the  International  Human  Frontier  Science  Program  Organisation,  the 
Commission  will  nominate  two  Members  to  the  Board  of  Trustees,  propose 
two  scientists  to  serve on  the  Council  of Scientists,  make  nominations 
to  the  Scientific  Review  Committees,  and  generally  give  positive 
support  to  the Programme. 75.  As  Initial  support  measures  for  the  Programme,  a  number  of  EC 
Scientific Training  fellowships  (existing  programmes)  will  be allocated 
to  fiFSP-related  research  areas,  and  International  worl<shops  w/11  be 
organised  on  related  state-of-the-art  topics.  The  cost  of  these 
activities will  be met  either  from  budget  line 7394,  Hlnternational  Co-
operation  and  COST  ActlvitiesH,  or  from  specific  programme  budget 
lines,  depending  on  the subject.  The  cost  of attending meetings  of  the 
various  IHFSPO  committees  w/11  be  met  by  the Organisation  Itself. 
16.  Since  the  International  HFSP  Organisation  Is  a  private non-governmental 
association,  registered  In  Strasbourg  under  French  civil  legislation, 
the  legal  basts  for  the  participation  of  the  Commission,  representing 
the  European  Economic  Community  as  a  "  lfanagement  Support lng Party"  Is 
Art.  211  of the  EEC  Treaty. 
17.  At  the end of the  trial  period  the Commission  w/11  assess  the extent  to 
which  HFSP's  objectives  are  being  achieved  and  evaluate  the  degree  of 
benefit  for  EC  Member  States.  If  It  Is  then  judged  of  value  to 
continue  participating  In  the  Programme,  a  further  communication  will 
be made  to Council  and  Parliament. ~-o  __  _!Ja.~_i_c_Hcscar~h  for:  the  Elucidation of Urain  Functions 
t,- I  I'EHCE!'T I ON  AND  COCN I T1 ON 
Vi SILl.!  Pcr·cept ion 
?  ~on-Vi  :;11.1!  l'f?l"<:f~!l t  i 011 
·1  M•Jlti-mod:-~1  J'(~•·ception 
•1.  :-;upr.l.-IIIO(bl  Co~niliort 
5.  Cogn it  i vc  l'sycho logy 
A.  ~odels of Perception  and  Cognition 
l  .  0 t IH~  r·  ~. 
/,- ~~  .'-lOI/Et!ENT  AND  BEHA VI Oll!l 
I. 
·- . 
3. 
(>. 
7. 
:'kciJ,1rtis•n  of  ,'lotor·  l'ro~p-aiJHIIilt~l 
(ogn it i ve  Control  of  /'lovcmcnt 
Adaptive  Contt·ol  o!  ~!ovcment 
I r111:1 te  !kh.-lV i our 
i~motional  Uellaviour· 
lntcllcct•Jal  Behaviour· 
F•mctiorl:1!  :1ol0.cllles  in  neh;l\'iOIIr 
0 thr·1· S 
:,  :1  :-li·.MOHY  /\Nil  1.1-:J\!lNINt: 
!'I"<)C<•dtll".ll  tl<.'IIIOI")'  .I lid  :)!, I II  L·~;ll"fl i ll<j 
(fJrJill t  1 Vl'  ,'ir•rnnr·y 
CtJ'jlll I  I \'P  i.t•;trll j II•J 
.,  lleVt'!nptn•~lll  ;111d  /\<jlll<j  of  ~j(~IIIOI"V 
/lc•v.'luprnenl  f)r  1.<~;11-llii;CJ 
()  :o)'II.IJ>1  IL  ~1···:11.'1111 :;m  o)r  ~i<'lll<l1")'  .tlld  L•'·l1"1lill~J 
~I•HJ,•Jo.  ol  Mt'IIIOI y  ,lfld  l(•arnill<J 
:-:  i_)  1 11 •• ,- ~ 
,\  ~  1./\1\'CIJ/d:E  MW  Till NK  IN<: 
I  .  Arl i 1na I  Commtlll i c;J l  i 011 
.-'  :\'europ~;ychology of  Lang11:tg<: 
."\•~<JJ".tl  i1<~clt;u,i~;m  ol  Tlti11kiW1 
<1  '\ 1 1 t • I I 1  I 0  II  ,If  I d  ( 0  II.'; I: j 0  II .';  II<~ .'•  ~. 
1
).  l.an~uage  Learn i n~J 
o.  Functional  Localizatior1 of  Language  and  Thinking 
?.  Mod(:ls  of  Lcarninq  and  Thinking 
~~  OLIIPIS 
s 
/\ f \llP;... -l.-
fl.  Jla:;ic  l!c•s<!ar·cft  lor  Lite Elucida.ti9!.1  ofB!gL~!9X<~j_Functions 
_!:~I_I"<HI~Jh  fl~>)  <!_(:~J !..~tr:  _!_:!!~~~Li\PP~yaches_ 
n-l  Z.:XI'HESSION  OF  GENETIC  !NFOI!MATION 
l.  fl.\'t1  il<~nl ir.ation  .111d  C.c•l  I  Cycle  Conu·ol 
/..  Transr.ri pt ion 
l.  Tr·anf;l;tt.ion.ll  Contr·ol 
<1.  Cis  El•!ments  and  Mot  i I" 
5.  Trans  Elements 
fi.  Gene  Rearrangements  and  Recombination 
"i.  Other·s 
ll-%  •'101\P!!OGENESIS 
I.  ., 
I. 
.1. 
4. 
5. 
c. 
/. 
llomeo-Box  and  r·c 1.1 t.ed  Genes 
1·-.;t.r:tc•'lltrlar- ~i:1trix 
Devclopmcntai  c;enc.s 
Gro1~th  F<lctors  ;Jnd  Function;tl  liicrat·chics 
Cell  Adhesion  and  Cell  Migr·ation 
Ol·~~;)jlO:JCrll!;, i :; 
()lit<!,.:.; 
B-3  MOLEClJLt.ll  HF.COGN!TJON  /\Nil  HESPONSES 
~olecular·  Level  Hes<.>ar·ch  in  Immunology 
?  ~o}f!r.ul:tr·  L<-vf!i  Hcse.1rch  in  Ncur  .. oblolo~1Y 
ll•·c·<!plor·-J.iq.lnd  lntc•r·.1r.t ior1 
I!  !'l<ll•'lll  l'r·otc•ill  l11lt>r:H:tio11 
5.  Prot~in-,'IJucleic  ."'cid  Interaction 
o  l'rol<'lll  or  :--;,H:l<'ic  1\r.i<l  Molec.11lar  I1C'C0~1nilion 
II  I •JII•'I  <II dt•t  \  l Ill•: II  II 1•:, 
H  ut.:1er!> 
rl<~ull> 1 ;uu:  E  I~~ c:  1 n>n i c s 
? .  l'ilo:;plws·y 1.1 t  io11  ~vs  t.<.•ms 
..1  l'i1oloiJiolo9y 
-1  I! i I) i c  ~~l i c :1  I  :'lo 1 i I i 1\' 
·,  I" f)(;l I  i Oil  ()I  :\ i I  t"()<JI'II 
(,  0 tlu.•r  ~. 
G ..  ~-
Hiqh-sp0ed  .1r1<i  Efficient  D~A Sequencing 
Tflt·~>f'  !lim<•rtsional  ~lructun~ l>etermil!ation  of  J'n)teins 
Nrm-Inv.l~.ive Mcasut·emcnt  of  Uiological  Functions 
Measurement  of  Dynamic  Structure of Oiological  Functions 
IJltra-:iicromanipulation 